NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunot...

Biotechnology

NewLink Genetics

NewLink Genetics' headquarters in Ames, IA, United States

Thomas Monath

Ryan Pint

Carl Langren

Eugene P. Kennedy

Nicholas N. Vahanian

Barb Hamilton

Mario Mautino

Helen Mao

The Research and Development team at NewLink Genetics is responsible for advancing the company's immunotherapeutic product pipeline. This includes the discovery and development of new biologic and small-molecule therapies, ensuring clinical efficacy, overseeing intellectual property, and optimizing process development for clinical trials and commercialization.

Research and Development

The Leadership Team at NewLink Genetics is responsible for setting the strategic direction of the company, guiding its clinical and commercial initiatives in immuno-oncology. This team, comprised of executives with diverse expertise in finance, science, and medicine, collaborates to drive innovation, oversee research and development, and ensure effective resource allocation to bring cutting-edge cancer therapies to market.

Leadership Team

This department manages financial operations and drives growth through strategic partnerships and project management.

NewLink Genetics

Org chart

Teams

Research and Development

Leadership Team

Accounting and Business Development

Offices

NewLink Genetics

Org chart

Teams

Research and Development

Leadership Team

Accounting and Business Development

Offices

Related companies